| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |